DrugsControl Media Services

News Detail

India to seek latest data on eicacy of Gilead’s Remdesivir following USFDA nod (24-10-2020)

New Delhi, 24 Oct 2020 : India’s Drug Regulatory authority will seek data from US based Gilead Sciences on the latest finding on the effectiveness of the antiviral drug Remdesivir in Covid-19 patients, after the US drug Regulator approved it as treatment for the disease. View Details

Source : Economic Times

Related News